Why we may abandon basal follicle-stimulating hormone testing: a sea change in determining ovarian reserve using antimüllerian hormone
- PMID: 23548941
- DOI: 10.1016/j.fertnstert.2013.03.001
Why we may abandon basal follicle-stimulating hormone testing: a sea change in determining ovarian reserve using antimüllerian hormone
Abstract
Antimüllerian hormone is the most informative serum marker of ovarian reserve currently available and should be considered an important part of any contemporary reproductive medicine practice. It is both more convenient and informative than basal FSH and can be assessed at any point in the cycle. It is the most useful serum method of determining ovarian reserve, which guides pretreatment counseling, choice of infertility treatment, and avoidance of ovarian hyperstimulation. The future role of basal FSH testing is in doubt.
Copyright © 2013 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Comment in
-
Use of antimüllerian hormone: the risks of interpreting ovarian reserve markers in isolation.Fertil Steril. 2013 Jun;99(7):1850. doi: 10.1016/j.fertnstert.2013.03.036. Epub 2013 Apr 19. Fertil Steril. 2013. PMID: 23608155 No abstract available.
Similar articles
-
Elevated body mass index is associated with lower serum anti-mullerian hormone levels in infertile women with diminished ovarian reserve but not with normal ovarian reserve.Fertil Steril. 2011 Jun;95(7):2364-8. doi: 10.1016/j.fertnstert.2011.03.081. Epub 2011 May 6. Fertil Steril. 2011. PMID: 21529798
-
Can highly sensitive antimüllerian hormone testing predict failed response to ovarian stimulation?Fertil Steril. 2015 Sep;104(3):643-8. doi: 10.1016/j.fertnstert.2015.06.018. Epub 2015 Jul 6. Fertil Steril. 2015. PMID: 26158904
-
Use of antimüllerian hormone: the risks of interpreting ovarian reserve markers in isolation.Fertil Steril. 2013 Jun;99(7):1850. doi: 10.1016/j.fertnstert.2013.03.036. Epub 2013 Apr 19. Fertil Steril. 2013. PMID: 23608155 No abstract available.
-
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).Hum Reprod Update. 2010 Mar-Apr;16(2):113-30. doi: 10.1093/humupd/dmp036. Epub 2009 Sep 30. Hum Reprod Update. 2010. PMID: 19793843 Review.
-
AMH: An ovarian reserve biomarker in assisted reproduction.Clin Chim Acta. 2014 Nov 1;437:175-82. doi: 10.1016/j.cca.2014.07.029. Epub 2014 Jul 30. Clin Chim Acta. 2014. PMID: 25086280 Review.
Cited by
-
Chemotherapy-induced damage to ovary: mechanisms and clinical impact.Future Oncol. 2016 Oct;12(20):2333-44. doi: 10.2217/fon-2016-0176. Epub 2016 Jul 12. Future Oncol. 2016. PMID: 27402553 Free PMC article. Review.
-
Assessment of ovarian reserve: Anti-Mullerian hormone versus follicle stimulating hormone.J Res Med Sci. 2016 Nov 2;21:100. doi: 10.4103/1735-1995.193172. eCollection 2016. J Res Med Sci. 2016. PMID: 28163746 Free PMC article.
-
Evaluation of Ovarian Reserve Tests and Age in the Prediction of Poor Ovarian Response to Controlled Ovarian Stimulation-A Real-World Data Analysis of 89,002 Patients.Front Endocrinol (Lausanne). 2021 Aug 30;12:702061. doi: 10.3389/fendo.2021.702061. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34526967 Free PMC article.
-
Antimüllerian hormone and pregnancy loss from the Effects of Aspirin in Gestation and Reproduction trial.Fertil Steril. 2016 Apr;105(4):946-952.e2. doi: 10.1016/j.fertnstert.2015.12.003. Epub 2015 Dec 17. Fertil Steril. 2016. PMID: 26707905 Free PMC article. Clinical Trial.
-
Study of Serum Anti-Mullerian Hormone in the Diagnosis of Ovarian Reserve Function in Patients with Premature Ovarian Insufficiency.Biomed Res Int. 2022 Oct 13;2022:3878359. doi: 10.1155/2022/3878359. eCollection 2022. Biomed Res Int. 2022. Retraction in: Biomed Res Int. 2023 Nov 1;2023:9875072. doi: 10.1155/2023/9875072 PMID: 36277874 Free PMC article. Retracted.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical